Abstract
Systemic lupus erythematosus (SLE) is a complex disease with varied clinical presentation and autoantibody production. It has previously been reported as rare in Black Africans. We established a Rheumatology clinic at the Kenyatta National Hospital in April 2010, and a 1 year audit of this clinic was carried out in September 2011. This is a report of this audit of patients who met the American College of Rheumatology (ACR) criteria for SLE. Thirteen patients met the ACR criteria; their mean age was 34 years, and they were all female. The commonest manifestations were malar rash and arthritis in 69.2 %. Antinuclear antibody was present in 79.6 %, and anti-dsDNA was present in 38.5 %. None of them had human immunodeficiency virus infection; 30 % had other comorbidities (hypertension, diabetes, and renal failure). Thirty percent also had an infection during this period. All these 13 were on prednisolone and 92 % of them were on hydroxychloroquine. There was no reported death during the study period. This confirms the presence of SLE in patients in Kenya who meet the ACR criteria.
References
Lau CS (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15:715–719
Trowell HC (1960) Non-infective disease in Africa. Arnold, London, p 145
Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46(9):1487–1491
Houman MH, Smiti-Khanfir M, Ben Ghorbell I et al (2004) Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients. Lupus 13(3):204–211
Davis P, Stein M (1991) SLE in Zimbabwean patients: a review of clinical and serologic features and evaluation of criteria for classification. Cent Afr J Med 37(9):282–285
Tan EM, Cohen AS, Fries JF, Masi AT et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
Patel M, Clarke AM, Bruce IN et al (2006) The prevalence and incidence of biopsy-proven lupus nephritis in the UK. Evidence of ethnic gradient. Arthritis Rheum 54(9):2963–2969
Kamen Diane L, Barron M, Prker TM et al (2008) Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum 58(5):1237–1247
Alarcon GS, Friedman AW, Straaton KV et al (1999) Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 8:197–209
AlSaleh J, Jassim V, ElSayed M et al (2008) Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus 17(1):62–66
Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 72:113–124
Acknowledgments
The author would like to thank the Kenyatta National Hospital management for commissioning and funding the audit, the senior Assistant Director of Medical Services; The Assistant Director Department of Medicine; Rheumatologists and Members of the records department at the Kenyatta National Hospital.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ekwom, P.E. Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin Rheumatol 32, 1215–1217 (2013). https://doi.org/10.1007/s10067-013-2217-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2217-3